Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Mar;17(3):273–281. doi: 10.1111/j.1365-2125.1984.tb02342.x

The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertensive men.

R G Wilcox, T Bennett, I A Macdonald, M Herbert, A M Skene
PMCID: PMC1463373  PMID: 6712861

Abstract

We have studied the physiological responses to 50 min of intermittent, moderate exercise in hypertensive men after the ingestion of a single dose of placebo, propranolol or metoprolol, and also after 28 days treatment. In addition, subjective assessments of mood were made during the last 7 days of each period of chronic treatment. Heart rate and blood pressure, both at rest and during exercise, were significantly reduced by a single dose of propranolol or metoprolol; more marked effects were observed after chronic treatment. Ventilation and gas exchange during exercise were only slightly disturbed by single doses of propranolol or metoprolol, whereas chronic treatment had no effect. Perceived exertion scores were increased after a single dose of either drug, compared to placebo, and the effect of propranolol was greater than that of metoprolol. With chronic treatment there were fewer differences between the perceived exertion scores during exercise, although 'leg' fatigue remained greater after propranolol than after placebo. Sweating from the forehead during exercise was enhanced by a single dose of either beta-adrenoceptor antagonist, with propranolol having the greater effect. After chronic treatment the effect of propranolol was diminished, whereas the effect of metoprolol was maintained. Very few disturbances of mood were found after chronic ingestion of the beta-adrenoceptor antagonists.

Full text

PDF
273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Carlsson E., Ek L. Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists. Life Sci I. 1973 Feb 1;12(3):107–119. doi: 10.1016/0024-3205(73)90368-8. [DOI] [PubMed] [Google Scholar]
  2. Anderson S. D., Bye P. T., Perry C. P., Hamor G. P., Theobald G., Nyberg G. Limitation of work performance in normal adult males in the presence of beta-adrenergic blockade. Aust N Z J Med. 1979 Oct;9(5):515–520. doi: 10.1111/j.1445-5994.1979.tb03387.x. [DOI] [PubMed] [Google Scholar]
  3. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2(2):92–98. [PubMed] [Google Scholar]
  4. CHALMERS T. M., KEELE C. A. The nervous and chemical control of sweating. Br J Dermatol. 1952 Feb;64(2):43–54. doi: 10.1111/j.1365-2133.1952.tb16160.x. [DOI] [PubMed] [Google Scholar]
  5. Davies C. T., Brotherhood J. R., ZeidiFard E. Effects of atropine and beta-blockade on temperature regulation and performance during prolonged exercise. Eur J Appl Physiol Occup Physiol. 1978 Apr 15;38(3):225–232. doi: 10.1007/BF00430081. [DOI] [PubMed] [Google Scholar]
  6. Ekblom B., Goldbarg A. N., Kilbom A., Astrand P. O. Effects of atropine and propranolol on the oxygen transport system during exercise in man. Scand J Clin Lab Invest. 1972 Sep;30(1):35–42. doi: 10.3109/00365517209081087. [DOI] [PubMed] [Google Scholar]
  7. Epstein S., Robinson B. F., Kahler R. L., Braunwald E. Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest. 1965 Nov;44(11):1745–1753. doi: 10.1172/JCI105282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Evans G. H., Shand D. G. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):487–493. doi: 10.1002/cpt1973144part1487. [DOI] [PubMed] [Google Scholar]
  9. Foster K. G., Haspineall J. R., Mollel C. L. Effects of propranolol on the response of human eccrine sweat glands to acetylcholine. Br J Dermatol. 1971 Oct;85(4):363–367. doi: 10.1111/j.1365-2133.1971.tb14031.x. [DOI] [PubMed] [Google Scholar]
  10. Haglund K., Collste P. Time course of blood pressure, pulse rate, plasma renin and metoprolol during treatment of hypertensive patients. Eur J Clin Pharmacol. 1980 May;17(5):321–328. doi: 10.1007/BF00558443. [DOI] [PubMed] [Google Scholar]
  11. Herbert M., Johns M. W., Doré C. Factor analysis of analogue scales measuring subjective feelings before and after sleep. Br J Med Psychol. 1976 Dec;49(4):373–379. doi: 10.1111/j.2044-8341.1976.tb02388.x. [DOI] [PubMed] [Google Scholar]
  12. Kendall M. J., John V. A., Quarterman C. P., Welling P. G. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol. Eur J Clin Pharmacol. 1980 Feb;17(2):87–92. doi: 10.1007/BF00562615. [DOI] [PubMed] [Google Scholar]
  13. Lamke L. O. An instrument for estimating evaporation from small skin surfaces. Scand J Plast Reconstr Surg. 1970;4(1):1–7. doi: 10.3109/02844317009038437. [DOI] [PubMed] [Google Scholar]
  14. Leenen F. H., Coenen C. H., Zonderland M., Maas A. H. Effects of cardioselective and nonselective beta-blockade on dynamic exercise performance in mildly hypertensive men. Clin Pharmacol Ther. 1980 Jul;28(1):12–21. doi: 10.1038/clpt.1980.124. [DOI] [PubMed] [Google Scholar]
  15. Leonetti G., Mayer G., Morganti A., Terzoli L., Zanchetti A., Bianchetti G., Di Salle E., Morselli P. L., Chidsey C. A. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl. 1975 Jun;48(6):491–499. doi: 10.1042/cs0480491. [DOI] [PubMed] [Google Scholar]
  16. MacDonald I. A., Bennett T., Gale E. A., Green J. H., Walford S. The effect of propranolol or metoprolol on thermoregulation during insulin-induced hypoglycaemia in man. Clin Sci (Lond) 1982 Sep;63(3):301–310. doi: 10.1042/cs0630301. [DOI] [PubMed] [Google Scholar]
  17. Macdonald I. A., Bennett T., Brown A. M., Wilcox R. G., Skene A. M. The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men. Br J Clin Pharmacol. 1984 Mar;17(3):283–293. doi: 10.1111/j.1365-2125.1984.tb02343.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Molnar G. W., Read R. C. Propranolol enhancement of hypoglycemic sweating. Clin Pharmacol Ther. 1974 May;15(5):490–496. doi: 10.1002/cpt1974155490. [DOI] [PubMed] [Google Scholar]
  19. Pearson S. B., Banks D. C., Patrick J. M. The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man. Br J Clin Pharmacol. 1979 Aug;8(2):143–148. doi: 10.1111/j.1365-2125.1979.tb05812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Petersen E. S., Whipp B. J., Davis J. A., Huntsman D. J., Brown H. V., Wasserman K. Effects of beta-adrenergic blockade on ventilation and gas exchange during exercise in humans. J Appl Physiol Respir Environ Exerc Physiol. 1983 May;54(5):1306–1313. doi: 10.1152/jappl.1983.54.5.1306. [DOI] [PubMed] [Google Scholar]
  21. Reybrouck T., Amery A., Billiet L. Hemodynamic response to graded exercise after chronic beta-adrenergic blockade. J Appl Physiol Respir Environ Exerc Physiol. 1977 Feb;42(2):133–138. doi: 10.1152/jappl.1977.42.2.133. [DOI] [PubMed] [Google Scholar]
  22. Twentyman O. P., Disley A., Gribbin H. R., Alberti K. G., Tattersfield A. E. Effect of beta-adrenergic blockade on respiratory and metabolic responses to exercise. J Appl Physiol Respir Environ Exerc Physiol. 1981 Oct;51(4):788–793. doi: 10.1152/jappl.1981.51.4.788. [DOI] [PubMed] [Google Scholar]
  23. Vandenburg M. J. The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients. Br J Clin Pharmacol. 1982 Nov;14(5):733–737. doi: 10.1111/j.1365-2125.1982.tb04965.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wilcox R. G., Bennett T., Brown A. M., Macdonald I. A. Is exercise good for high blood pressure? Br Med J (Clin Res Ed) 1982 Sep 18;285(6344):767–769. doi: 10.1136/bmj.285.6344.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wilcox R. G., Hampton J. R. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension. Br Heart J. 1981 Nov;46(5):498–502. doi: 10.1136/hrt.46.5.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zacharias F. J. Patient acceptability of propranolol and the occurence of side effects. Postgrad Med J. 1976;52 (Suppl 4):87–89. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES